Chisari F V, Isogawa M, Wieland S F
Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Pathol Biol (Paris). 2010 Aug;58(4):258-66. doi: 10.1016/j.patbio.2009.11.001. Epub 2010 Feb 8.
The adaptive immune response is thought to be responsible for viral clearance and disease pathogenesis during hepatitis B virus infection. It is generally acknowledged that the humoral antibody response contributes to the clearance of circulating virus particles and the prevention of viral spread within the host while the cellular immune response eliminates infected cells. The T cell response to the hepatitis B virus (HBV) is vigorous, polyclonal and multispecific in acutely infected patients who successfully clear the virus and relatively weak and narrowly focussed in chronically infected patients, suggesting that clearance of HBV is T cell dependent. The pathogenetic and antiviral potential of the cytotoxic T lymphocyte (CTL) response to HBV has been proven by the induction of a severe necroinflammatory liver disease following the adoptive transfer of HBsAg specific CTL into HBV transgenic mice. Remarkably, the CTLs also purge HBV replicative intermediates from the liver by secreting type 1 inflammatory cytokines thereby limiting virus spread to uninfected cells and reducing the degree of immunopathology required to terminate the infection. Persistent HBV infection is characterized by a weak adaptive immune response, thought to be due to inefficient CD4+ T cell priming early in the infection and subsequent development of a quantitatively and qualitatively ineffective CD8+ T cell response. Other factors that could contribute to viral persistence are immunological tolerance, mutational epitope inactivation, T cell receptor antagonism, incomplete down-regulation of viral replication and infection of immunologically privileged tissues. However, these pathways become apparent only in the setting of an ineffective immune response, which is, therefore, the fundamental underlying cause. Persistent infection is characterized by chronic liver cell injury, regeneration, inflammation, widespread DNA damage and insertional deregulation of cellular growth control genes, which, collectively, lead to cirrhosis of the liver and hepatocellular carcinoma.
适应性免疫反应被认为在乙型肝炎病毒感染期间负责病毒清除和疾病发病机制。一般认为,体液抗体反应有助于清除循环中的病毒颗粒并防止病毒在宿主体内传播,而细胞免疫反应则消除被感染的细胞。在成功清除病毒的急性感染患者中,T细胞对乙型肝炎病毒(HBV)的反应强烈、多克隆且具有多特异性,而在慢性感染患者中则相对较弱且聚焦范围狭窄,这表明HBV的清除依赖于T细胞。将HBsAg特异性细胞毒性T淋巴细胞(CTL)过继转移到HBV转基因小鼠后,引发了严重的坏死性炎症性肝病,这证明了CTL对HBV的致病和抗病毒潜力。值得注意的是,CTL还通过分泌1型炎性细胞因子从肝脏中清除HBV复制中间体,从而限制病毒传播到未感染的细胞,并降低终止感染所需的免疫病理学程度。持续性HBV感染的特征是适应性免疫反应较弱,这被认为是由于感染早期CD4 + T细胞启动效率低下,以及随后出现数量和质量上均无效的CD8 + T细胞反应。其他可能导致病毒持续存在的因素包括免疫耐受、突变表位失活、T细胞受体拮抗、病毒复制的不完全下调以及免疫特权组织的感染。然而,这些途径仅在免疫反应无效的情况下才会显现出来,因此,免疫反应无效是根本的潜在原因。持续性感染的特征是慢性肝细胞损伤、再生、炎症、广泛的DNA损伤以及细胞生长控制基因的插入失调,这些共同导致肝硬化和肝细胞癌。